Patients with kidney failure commonly require dialysis to remove nitrogenous wastes and to reduce burden to the kidney. Here, we show that a bacterial cocktail orally delivered in animals with kidney injury can metabolize blood nitrogenous waste products before they diffuse through the intestinal mucosal barrier. The microbial cocktail consists of three strains of bacteria isolated from faecal microbiota that metabolize urea and creatinine into amino acids, and is encapsulated in calcium alginate microspheres coated with a polydopamine layer that is selectively permeable to small-molecule nitrogenous wastes. In murine models of acute kidney injury and chronic kidney failure, and in porcine kidney failure models, the encapsulated microbial cocktail significantly reduced urea and creatinine concentrations in blood, and did not lead to any adverse effects.
Subscribe to Journal
Get full journal access for 1 year
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
The main data supporting the results of this study are available within the paper and its Supplementary Information. The raw and analysed datasets generated during this study are too large to be publicly shared, yet they are available for research purposes from the corresponding authors on reasonable request.
Sharples, E. J., Thiemermann, C. & Yaqoob, M. M. Mechanisms of disease: cell death in acute renal failure and emerging evidence for a protective role of erythropoietin. Nat. Clin. Pract. Nephr. 1, 87–97 (2005).
Liu, Z. H. Nephrology in China. Nat. Rev. Nephrol. 9, 523–528 (2013).
Yang, L. et al. Acute kidney injury in China: a cross-sectional survey. Lancet 386, 1465–1471 (2015).
Yu, X. Q. & Yang, X. Peritoneal dialysis in China: meeting the challenge of chronic kidney failure. Am. J. Kidney Dis. 65, 147–151 (2015).
Wolfe, R. A. et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 341, 1725–1730 (1999).
Jiang, D. W. et al. DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury. Nat. Biomed. Eng. 2, 865–877 (2018).
Forster, V., Signorell, R. D., Roveri, M. & Leroux, J. C. Liposome-supported peritoneal dialysis for detoxification of drugs and endogenous metabolites. Sci. Transl. Med. 6, 258ra141 (2014).
Hu, C. M. J., Fang, R. H., Copp, J., Luk, B. T. & Zhang, L. F. A biomimetic nanosponge that absorbs pore-forming toxins. Nat. Nanotechnol. 8, 336–340 (2013).
Balimane, P. V. & Chong, S. Cell culture-based models for intestinal permeability: a critique. Drug. Discov. Today 10, 335–343 (2005).
Buttini, F., Colombo, P., Rossi, A., Sonvico, F. & Colombo, G. Particles and powders: tools of innovation for non-invasive drug administration. J. Control. Release 161, 693–702 (2012).
Hooper, L. V., Littman, D. R. & Macpherson, A. J. Interactions between the microbiota and the immune system. Science 336, 1268–1273 (2012).
Nicholson, J. K. et al. Host-gut microbiota metabolic interactions. Science 336, 1262–1267 (2012).
Cani, P. D. Microbiota and metabolites in metabolic diseases. Nat. Rev. Endocrinol. 15, 69–70 (2019).
Zheng, X. et al. Melamine-induced renal toxicity is mediated by the gut microbiota. Sci. Transl. Med. 5, 172ra22 (2013).
Zhao, L. et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359, 1151–1156 (2018).
Din, M. O. et al. Synchronized cycles of bacterial lysis for in vivo delivery. Nature 536, 81–85 (2016).
Isabella, V. M. et al. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat. Biotechnol. 36, 857–864 (2018).
Li, C. X. et al. Artificially reprogrammed macrophages as tumor-tropic immunosuppression-resistant biologics to realize therapeutics production and immune activation. Adv. Mater. 31, 1807211 (2019).
Zheng, D. W. et al. Optically-controlled bacterial metabolite for cancer therapy. Nat. Commun. 9, 1680 (2018).
Zheng, D. W. et al. Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy. Nat. Biomed. Eng. 3, 717–728 (2019).
Shen, T. C. D. et al. Engineering the gut microbiota to treat hyperammonemia. J. Clin. Invest. 125, 2841–2850 (2015).
Wang, X. S., Zeng, J. Y., Zhang, M. K., Zeng, X. & Zhang, X. Z. A versatile Pt-based core–shell nanoplatform as a nanofactory for enhanced tumor therapy. Adv. Funct. Mater. 28, 1801783 (2018).
Richardson, A. J., McKain, N. & Wallace, R. J. Ammonia production by human faecal bacteria, and the enumeration, isolation and characterization of bacteria capable of growth on peptides and amino acids. BMC Microbiol. 13, 6 (2013).
Matoori, S. & Leroux, J. C. Recent advances in the treatment of hyperammonemia. Adv. Drug Deliv. Rev. 90, 55–68 (2015).
Zheng, D. W. et al. Hierarchical micro-/nanostructures from human hair for biomedical applications. Adv. Mater. 30, 201800836 (2018).
Koppe, L. et al. Urea impairs beta cell glycolysis and insulin secretion in chronic kidney disease. J. Clin. Invest. 126, 3598–3612 (2016).
Lau, W. L. & Vaziri, N. D. Urea, a true uremic toxin: the empire strikes back. Clin. Sci. 131, 3–12 (2017).
Trivin, C. et al. Glycated hemoglobin level and mortality in a nondiabetic population with CKD. Clin. J. Am. Soc. Nephrol. 10, 957–964 (2015).
Koeth, R. A. et al. Protein carbamylation predicts mortality in ESRD. J. Am. Soc. Nephrol. 24, 853–861 (2013).
Vaziri, N. D. et al. Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am. J. Nephrol. 37, 1–6 (2013).
McIntyre, C. W. et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 133–141 (2011).
Derrien, M. & van Hylckama Vlieg, J. E. T. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol. 23, 354–366 (2015).
Hasani-Sadrabadi, M. M. et al. Mechanobiological mimicry of helper T lymphocytes to evaluate cell–biomaterials crosstalk. Adv. Mater. 30, 1706780 (2018).
Lee, Y. et al. Therapeutic luminal coating of the intestine. Nat. Mater. 17, 834–842 (2018).
Hu, C. M. et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature 526, 118–121 (2015).
Ni, J., Wu, G. D., Albenberg, L. & Tomov, V. T. Gut microbiota and IBD: causation or correlation? Nat. Rev. Gastroenterol. Hepatol. 14, 573–584 (2017).
Battaglioli, E. J. et al. Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea. Sci. Transl. Med. 10, eaam7019 (2018).
Fan, J. X. et al. Bacteria-mediated tumor therapy utilizing photothermally-controlled TNF-α expression via oral administration. Nano Lett. 18, 2373–2380 (2018).
Alidori, S. et al. Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury. Sci. Transl. Med. 8, 331ra39 (2016).
Kurtz, C. B. et al. An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci. Transl. Med. 11, eaau7975 (2019).
Belliere, J. et al. Specific macrophage subtypes influence the progression of rhabdomyolysis-induced kidney injury. J. Am. Soc. Nephrol. 26, 1363–1377 (2015).
Cui, J. et al. Rapamycin protects against gentamicin-induced acute kidney injury via autophagy in mini-pig models. Sci. Rep. 5, 11256 (2015).
Yu, M., Liu, J., Ning, X. & Zheng, J. High-contrast noninvasive imaging of kidney clearance kinetics enabled by renal clearable nanofluorophores. Angew. Chem. Int. Ed. 54, 15434–15438 (2015).
This work was supported by the National Key Research and Development Program of China (2019YFA0905603) and National Natural Science Foundation of China (51988102, 51833007, 51690152, 51573142 and 21721005).
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zheng, DW., Pan, P., Chen, KW. et al. An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure. Nat Biomed Eng 4, 853–862 (2020). https://doi.org/10.1038/s41551-020-0582-1
Nano Letters (2021)
Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy
Drug Delivery (2021)
Biodegradable Self‐Assembled Ultrasmall Nanodots as Reactive Oxygen/Nitrogen Species Scavengers for Theranostic Application in Acute Kidney Injury
Cross-feeding and wheat straw extractives enhance growth of Clostridium thermocellum-containing co-cultures for consolidated bioprocessing
Bioprocess and Biosystems Engineering (2021)
Advanced Therapeutics (2021)